Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100050263 | 10005026 | 3 | F | 20160720 | 20140312 | 20160720 | EXP | BD-BRISTOL-MYERS SQUIBB COMPANY-20469391 | BRISTOL MYERS SQUIBB | 0.00 | A | F | Y | 0.00000 | 20160720 | OT | BD | BD |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100050263 | 10005026 | 1 | PS | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Unknown | 500 MG, TID | U | 20357 | 500 | MG | TID | ||||||
| 100050263 | 10005026 | 2 | SS | FOLLITROPIN ALFA | FOLLITROPIN | 1 | Unknown | 75 IU, UNK | U | 0 | 75 | IU | |||||||
| 100050263 | 10005026 | 3 | C | HUMAN CHORIONIC GONADOTROPHIN | 2 | Intramuscular | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100050263 | 10005026 | 1 | Polycystic ovaries |
| 100050263 | 10005026 | 2 | Ovulation induction |
| 100050263 | 10005026 | 3 | Ovulation induction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100050263 | 10005026 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100050263 | 10005026 | Ectopic pregnancy | |
| 100050263 | 10005026 | Maternal exposure during pregnancy | |
| 100050263 | 10005026 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |